CHEMED CORP
For the period ended Jun 30, 2024. Filed Jul 26, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Jul 26, 2024
CHE$544.49+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Consolidated Statements of Changes in Stockholders’ Equity-
| CHEMED CORPORATION AND SUBSIDIARY COMPANIES | ||||||
|---|---|---|---|---|---|---|
| UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY | ||||||
| (in thousands, except per share data) | ||||||
| For the three months ended June 30, 2024 and 2023: | Deferred | |||||
| Compensation | ||||||
| Treasury · Payable in | ||||||
| Capital · Paid-in · Retained · Stock- · Company | ||||||
| Stock | Capital | Earnings | at Cost | Stock | Total | |
| Balance at March 31, 2024 | $37,297 | $1,398,733 | $2,505,892 | $(2,760,543) | $2,116 | $1,183,495 |
| Net income | - | - | 70,887 | - | - | 70,887 |
| Dividends paid ($0.40 per share) | - | - | (6,057) | - | - | (6,057) |
| Stock awards and exercise of stock options | 16 | 17,555 | - | (2,709) | - | 14,862 |
| Purchases of treasury stock | - | - | - | (55,769) | - | (55,769) |
| Other | - | (122) | - | (32) | 33 | (121) |
| Balance at June 30, 2024 | $37,313 | $1,416,166 | $2,570,722 | $(2,819,053) | $2,149 | $1,207,297 |
| Deferred | ||||||
| Compensation | ||||||
| Treasury · Payable in | ||||||
| Capital · Paid-in · Retained · Stock- · Company | ||||||
| Stock | Capital | Earnings | at Cost | Stock | Total | |
| Balance at March 31, 2023 | $36,884 | $1,186,119 | $2,246,354 | $(2,591,588) | $2,284 | $880,053 |
| Net income | - | - | 53,377 | - | - | 53,377 |
| Dividends paid ($0.38 per share) | - | - | (5,727) | - | - | (5,727) |
| Stock awards and exercise of stock options | 112 | 53,657 | - | (16,608) | - | 37,161 |
| Purchases of treasury stock | - | - | - | (13,425) | - | (13,425) |
| Other | - | 639 | - | (36) | 37 | 640 |
| Balance at June 30, 2023 | $36,996 | $1,240,415 | $2,294,004 | $(2,621,657) | $2,321 | $952,079 |
| See Accompanying Notes to Unaudited Consolidated Financial Statements. | ||||||
-6-
| CHEMED CORPORATION AND SUBSIDIARY COMPANIES | ||||||
|---|---|---|---|---|---|---|
| UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY | ||||||
| (in thousands, except per share data) | ||||||
| For the six months ended June 30, 2024 and 2023: | Deferred | |||||
| Compensation | ||||||
| Treasury · Payable in | ||||||
| Capital · Paid-in · Retained · Stock- · Company | ||||||
| Stock | Capital | Earnings | at Cost | Stock | Total | |
| Balance at December 31, 2023 | $37,184 | $1,341,273 | $2,446,925 | $(2,719,588) | $2,082 | $1,107,876 |
| Net income | - | - | 135,904 | - | - | 135,904 |
| Dividends paid ($0.80 per share) | - | - | (12,107) | - | - | (12,107) |
| Stock awards and exercise of stock options | 129 | 75,667 | - | (11,286) | - | 64,510 |
| Purchases of treasury stock | - | - | - | (88,113) | - | (88,113) |
| Other | - | (774) | - | (66) | 67 | (773) |
| Balance at June 30, 2024 | $37,313 | $1,416,166 | $2,570,722 | $(2,819,053) | $2,149 | $1,207,297 |
| Deferred | ||||||
| Compensation | ||||||
| Treasury · Payable in | ||||||
| Capital · Paid-in · Retained · Stock- · Company | ||||||
| Stock | Capital | Earnings | at Cost | Stock | Total | |
| Balance at December 31, 2022 | $36,796 | $1,149,899 | $2,197,918 | $(2,588,145) | $2,247 | $798,715 |
| Net income | - | - | 107,498 | - | - | 107,498 |
| Dividends paid ($0.76 per share) | - | - | (11,412) | - | - | (11,412) |
| Stock awards and exercise of stock options | 200 | 89,995 | - | (20,014) | - | 70,181 |
| Purchases of treasury stock | - | - | - | (13,425) | - | (13,425) |
| Other | - | 521 | - | (73) | 74 | 522 |
| Balance at June 30, 2023 | $36,996 | $1,240,415 | $2,294,004 | $(2,621,657) | $2,321 | $952,079 |
| See Accompanying Notes to Unaudited Consolidated Financial Statements. | ||||||
-7-
CHEMED CORPORATION AND SUBSIDIARY COMPANIES
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.